COMMUNIQUÉS West-GlobeNewswire

Healthwise® Orthopedic Decision Aids Receive Certification From Washington State Health Care Authority
28/11/2017
BOISE, Idaho, Nov. 28, 2017 (GLOBE NEWSWIRE) -- The Washington State Health Care Authority announced the certification of Healthwise decision aids as part of an effort in Washington to put evidence-based information [...]
Insmed to Present at the Nasdaq 37th Annual Investor Conference
28/11/2017
BRIDGEWATER, N.J., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that Will Lewis, [...]
CinRx Closes $10 Million Series B Financing
28/11/2017
CINCINNATI, Nov. 28, 2017 (GLOBE NEWSWIRE) -- CinRx, a biopharmaceutical company with an innovative approach to developing novel therapeutics that address diverse therapeutic areas, announced today the completion of its [...]
Argos Provides Financial Update
28/11/2017
DURHAM, N.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
TESARO Announces Availability of VARUBI® (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy in the United States
28/11/2017
VARUBI injectable emulsion features ready-to-use, single-dose vial No saline, reconstitution or mixing is required to utilize VARUBI IV New formulation offers healthcare providers flexibility in their choice of [...]
PhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor
28/11/2017
First-in-class and unique reversal agent for ticagrelor aims to address important unmet need for patients requiring antiplatelet therapy Potential for accelerated development timeline with Phase 1 initiation expected in [...]
Provant Vice President of Client Management Elizabeth Merritt, Esq., is featured prominently in a recent Bloomberg Law article on wellness program incentives
28/11/2017
EAST GREENWICH, R.I., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Provant Vice President of Client Management Elizabeth Merritt, Esq., is featured prominently in a recent Bloomberg Law article on wellness program incentives. [...]
Neos Therapeutics to Participate in Two December Conferences
28/11/2017
DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR [...]
Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting on February 17, 2018
28/11/2017
BUFFALO, N.Y., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Zogenix To Host Call with Pediatric Epilepsy Expert Joseph Sullivan, M.D., on Dravet Syndrome and ZX008 on Monday, December 4
28/11/2017
EMERYVILLE, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
PositiveID Projects Revenue Growth of More Than 30% Year-over-Year through First Quarter of 2018
28/11/2017
DELRAY BEACH, Fla., Nov. 28, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, today announced that it projects consolidated year-over-year revenue [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
28/11/2017
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]
Transactions in relation to share buyback program
28/11/2017
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Arch Therapeutics to Provide Corporate Update at the 10th Annual LD Micro Main Event In Los Angeles December 5-7, 2017
28/11/2017
FRAMINGHAM, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent
28/11/2017
RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing today announced that on November 21, 2017, the U.S. Patent and Trademark [...]
Aptevo Therapeutics Announces Plans to Conduct Phase 2 Study of Otlertuzumab in Peripheral T-Cell Lymphoma
28/11/2017
Anticipates 2 IND Filings in 2018 for Novel Bispecific Antibody Candidates SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2017
28/11/2017
CARLSBAD, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial results for the three and nine months ended September 30, 2017. To our [...]
Deciphera Pharmaceuticals, Inc. Announces Orphan Drug Designation from the EMA for DCC-2618 for the Treatment of Gastrointestinal Stromal Tumors
28/11/2017
WALTHAM, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH ) a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced [...]
G1 Therapeutics and AstraZeneca Enter Clinical Trial Collaboration in Non-Small Cell Lung Cancer
28/11/2017
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ: GTHX ), a clinical-stage oncology company, today announced a clinical trial collaboration with AstraZeneca to evaluate [...]

Pages